Nautilus 2014 Annual Report Download - page 13

Download and view the complete annual report

Please find page 13 of the 2014 Nautilus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 77

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77

disruption in our supply chain and operations.
Our inventory purchases are subject to long lead times, which could negatively impact our sales, cash flows and liquidity.
All of our products are produced by third-
party manufacturers, substantially all of which are located in Asia, primarily China. Lead times for
months, of which transit time represents three-to-
four weeks. The length of our lead times requires us to place advance manufacturing orders
such items.
A delay in getting non-U.S.-
sourced products through port operations and customs in a timely manner could result in reduced sales,
canceled sales orders and unanticipated inventory accumulation.
results, financial position and cash flows.
Unpredictable events and circumstances relating to our international operations, including our use of non-
U.S. manufacturers, could
have a material adverse effect on our business.
material adverse effect on our operating results, financial position and cash flows.
Currency exchange rate fluctuations could result in higher costs, reduced margins or decreased international sales.
flows.
patent expiration. Increased competition in those product categories could negatively affect our future revenues and operating results.
A patent covering aspects of our TreadClimber
®
products expired during 2013. Although we own a number of other patents covering aspects of
our TreadClimber
®
products, the introduction of comparable products designed to compete with our TreadClimber
®
line of specialized cardio
machines may increase in the future as a result of these patent expirations. Sales of cardio products, including Bowflex TreadClimber
®
products,
or other factors could result in a decline in our revenues derived
9